Publications

Showing 2 of 2 Publications

2019

Pharmacodynamic Responses to CC-90009, a Novel Cereblon E3 Ligase Modulator, in a Phase I Dose-Escalation Study in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
Fan J, Wang H, Couto S, Yao T, Uy G, Zeidan A, Minden M, Montesinos P, DeAngelo D, Altman J, Koprivnikar J, Vyas P, Fløisand Y, Vidriales M, Gjertsen B, Buchholz T, Pourdehnad M, Pierce D. Pharmacodynamic Responses to CC-90009, a Novel Cereblon E3 Ligase Modulator, in a Phase I Dose-Escalation Study in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML). Blood 2019, 134: 2547. DOI: 10.1182/blood-2019-124291.
Peer-Reviewed Original Research
Concepts

1978

IMMUNOLOGICAL STUDIES OF HUMAN Ia-LIKE ANTIGENS11This work was supported by research grants from the U.S. Public Health Service (N.I.H. AI-10736 and AI-09576). A.F. is a fellow of the Medical Research Council, Canada. M.G.'s involvement was sponsored in part by the Dutch Organization for the Advancement of Pure Research. B.S.'s work was supported in part by the Norwegian Cancer Society
Kaufman J, Fuks A, Giphart M, Solheim B, Strominger J. IMMUNOLOGICAL STUDIES OF HUMAN Ia-LIKE ANTIGENS11This work was supported by research grants from the U.S. Public Health Service (N.I.H. AI-10736 and AI-09576). A.F. is a fellow of the Medical Research Council, Canada. M.G.'s involvement was sponsored in part by the Dutch Organization for the Advancement of Pure Research. B.S.'s work was supported in part by the Norwegian Cancer Society. 1978, 235-241. DOI: 10.1016/b978-0-12-483260-2.50030-6.
Peer-Reviewed Original Research
Concepts

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply